LILLY PROZAC SALES INCREASE 7% TO $580.7 MIL. IN THIRD QUARTER; PFIZER NORVASC SUPPLANTS PROCARDIA XL AS TOP PRODUCT WITH $899.8 MIL. YEAR-TO-DATE

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".